Skip to main content

Find Clinical Trials

Home
Conditions
Dyslipidemias

Clinical trial condition

Dyslipidemias

Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.

1,810 public trials 143 recruiting studies

Refine in advanced search Browse all conditions

Dyslipidemias trial results

Completed

A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol

NCT00136942

Conditions: Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
Locations: Pfizer Investigational Site Binningen, Basel-Landschaft, Switzerland

Pfizer Investigational Site Liestal, Basel-Landschaft, Switzerland

Pfizer Investigational Site Basel, Canton of Basel-City, Switzerland

Pfizer Investigational Site Langenthal, Canton of Bern, Switzerland

View all 20 locations

View Trial Details

Completed

HDDO-1756 Bio Equivalence Study

NCT04755894

Conditions: Dyslipidemias, Hyperlipidemias, Lipid Metabolism Disorders, +2 more
Locations: Hyundai Pharm Seoul, South Korea

View Trial Details

Completed

Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe

NCT02772640

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Behavior, +16 more
Locations: Cardiology Department, Dr. A. Jurasz University Hospital Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

View Trial Details

Completed

Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients

NCT04148001

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +19 more
Locations: Excel Medical Clinical Trials, LLC Boca Raton, Florida, United States

View Trial Details

Completed

Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

NCT03371355

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, +13 more
Locations: Clinical Sites Chandler, Arizona, United States

Clinical Site Fountain Hills, Arizona, United States

Clinical Site Glendale, Arizona, United States

Clinical Site Mesa, Arizona, United States

View all 42 locations

View Trial Details

Completed

Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

NCT01107743

Conditions: Angina Pectoris, Cardiovascular Diseases, Chest Pain, +21 more
Locations: Not specified

View Trial Details

Completed

Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients

NCT01190007

Conditions: Angina Pectoris, Cardiovascular Diseases, Chest Pain, +14 more
Locations: Healthcare Corporation MEDOC Medical Dock&Clinic Nagoya, Aichi-ken, Japan

Beppu Medical Clinic Dazaifu, Fukuoka, Japan

Morizono medical clinic Kitakyushu, Fukuoka, Japan

Gakkentoshi Clinic Nishiku, Fukuoka, Japan

View all 20 locations

View Trial Details

Completed

Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors

NCT00407537

Conditions: Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +6 more
Locations: Pfizer Investigational Site Desamparados, Provincia de San José, Costa Rica

Pfizer Investigational Site Heredia, Costa Rica

Pfizer Investigational Site San José, Costa Rica

Pfizer Investigational Site Breznički Hum, Croatia

View all 125 locations

View Trial Details

Completed

A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects

NCT02374047

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Spaulding Clinical Research West Bend, Wisconsin, United States

View Trial Details

Completed

A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin

NCT00530946

Conditions: Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +6 more
Locations: Pfizer Investigational Site Fukuoka, Japan

Pfizer Investigational Site Kitakyushu-shi, Fukuoka, Japan

Pfizer Investigational Site Kurume-shi, Fukuoka, Japan

Pfizer Investigational Site Maebaru-shi, Fukuoka, Japan

View all 17 locations

View Trial Details